Hartmut Beug

Active 1970–2014

112
Papers
26,989
Citations
90
h-index
112
i10-index

Citations

Citations per year for Hartmut Beug1926: 1 citations1971: 1 citations1972: 1 citations1973: 6 citations1974: 3 citations1975: 8 citations1976: 6 citations1977: 8 citations1978: 21 citations1979: 26 citations1980: 30 citations1981: 33 citations1982: 66 citations1983: 71 citations1984: 100 citations1985: 45 citations1986: 88 citations1987: 92 citations1988: 126 citations1989: 83 citations1990: 121 citations1991: 117 citations1992: 96 citations1993: 125 citations1994: 66 citations1995: 82 citations1996: 86 citations1997: 76 citations1998: 104 citations1999: 102 citations2000: 145 citations2001: 181 citations2002: 197 citations2003: 240 citations2004: 282 citations2005: 336 citations2006: 348 citations2007: 373 citations2008: 422 citations2009: 431 citations2010: 384 citations2011: 409 citations2012: 377 citations2013: 327 citations2014: 292 citations2015: 233 citations2016: 186 citations2017: 224 citations2018: 170 citations2019: 528 citations2020: 457 citations2021: 434 citations2022: 278 citations2023: 167 citations2024: 264 citations2025: 74 citations2026: 5 citations1927–1970: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,207 citing papers, 32.4% of this breakdownChina: 1,001 citing papers, 10.1% of this breakdownGermany: 723 citing papers, 7.3% of this breakdownUnited Kingdom: 532 citing papers, 5.4% of this breakdownFrance: 414 citing papers, 4.2% of this breakdownJapan: 361 citing papers, 3.6% of this breakdownItaly: 296 citing papers, 3% of this breakdownAustria: 276 citing papers, 2.8% of this breakdownCanada: 269 citing papers, 2.7% of this breakdownSpain: 246 citing papers, 2.5% of this breakdownAustralia: 210 citing papers, 2.1% of this breakdownNetherlands: 205 citing papers, 2.1% of this breakdown
0%32.4%Other 21.8%

Fields

  • Biochemistry, Genetics and Molecular Biology52.9%
  • Medicine36.9%
  • Immunology and Microbiology4.2%
  • Neuroscience1.8%
  • Agricultural and Biological Sciences1.7%
  • Chemistry0.4%
  • Other2.1%

Topics

  • Cancer Cells and Metastasis5.6%
  • TGF-β signaling in diseases2.5%
  • Wnt/β-catenin signaling in development and cancer2.4%
  • Cytokine Signaling Pathways and Interactions1.8%
  • Epigenetics and DNA Methylation1.8%
  • Cancer-related molecular mechanisms research1.7%
  • Other84.2%

Coauthors

All papers

Open in search
  1. Membrane lipidome of an epithelial cell line

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 515

  2. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

    Authors: , , , , , , , , - Journal of Clinical Investigation 2004 cited by 894

  3. Molecular requirements for epithelial–mesenchymal transition during tumor progression

    Authors: , , - Current Opinion in Cell Biology 2005 cited by 1,817

  4. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells

    Authors: , , , , , , , , , - Oncogene 2005 cited by 796

  5. Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor Growth

    Authors: , , , , , , , , , , , , , , - Neoplasia 2005 cited by 433

  6. The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity

    Authors: , , , , , , , , , , , , , , , - Oncogene 2007 cited by 612

  7. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression

    Authors: , , , , , , , , , - Cell Death and Differentiation 2014 cited by 175

  8. The glucocorticoid receptor is required for stress erythropoiesis

    Authors: , , , , , , , - Genes & Development 1999 cited by 296

  9. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis

    Authors: , , , , , , , - The Journal of Cell Biology 2002 cited by 697

  10. p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway

    Authors: , , , , , , , , , - Nature Genetics 2007 cited by 354

  11. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.

    Authors: , , , , , - Genes & Development 1996 cited by 682

  12. E-cadherin regulates cell growth by modulating proliferation-dependent β -catenin transcriptional activity

    Authors: , , , , - The Journal of Cell Biology 2001 cited by 334

  13. The c-erb-A protein is a high-affinity receptor for thyroid hormone

    Authors: , , , , , , , - Nature 1986 cited by 1,343

  14. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis

    Authors: , , - Nature Reviews Molecular Cell Biology 2003 cited by 678

  15. Translation control: bridging the gap between genomics and proteomics?

    Authors: , , , , - Trends in Biochemical Sciences 2001 cited by 393

  16. The Glucocorticoid Receptor Cooperates With the Erythropoietin Receptor and c-Kit to Enhance and Sustain Proliferation of Erythroid Progenitors In Vitro

    Authors: , , , , , , , - Blood 1999 cited by 242

  17. Stat5 is indispensable for the maintenance of bcr/abl‐positive leukaemia

    Authors: , , , , , , , , , , , , , , - EMBO Molecular Medicine 2010 cited by 232

  18. NF-κB promotes epithelial–mesenchymal transition, migration and invasion of pancreatic carcinoma cells

    Authors: , , , , , - Cancer Letters 2010 cited by 210

  19. Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge

    Authors: , , , , , , , , , - Oncogene 2009 cited by 171

  20. The glucocorticoid receptor is a key regulator of the decision between self‐renewal and differentiation in erythroid progenitors

    Authors: , , , - The EMBO Journal 1997 cited by 158

  21. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis

    Authors: , , - Current Biology 1998 cited by 621

  22. STAT1 acts as a tumor promoter for leukemia development

    Authors: , , , , , , , , , - Cancer Cell 2006 cited by 155

  23. Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis

    Authors: , , , , , , , , , , , , , - Cell 2011 cited by 154

  24. Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation

    Authors: , , , , - Cell 1979 cited by 783